BEUDAMED
    FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

    Acid, Hyaluronic, Intraarticular

    PMA: P010029 · Supplement: S037 · Decision Mar 1, 2024
    View on FDA
    Classifications
    1
    FEI Numbers
    21
    Registration Numbers
    21

    Basic Information

    Device Name
    Acid, Hyaluronic, Intraarticular
    Trade Name
    EUFLEXXA
    PMA Number
    P010029
    Supplement Number
    S037
    Device Class
    FDA Class 3
    Product Code
    MOZ
    Generic Name
    Acid, hyaluronic, intraarticular
    Medical Specialty
    Unknown
    Advisory Committee
    Orthopedic
    Decision
    30-Day Notice Accepted
    Decision Code
    OK30
    Decision Date
    March 1, 2024
    Date Received
    February 5, 2024
    Supplement Type
    30-Day Notice
    Supplement Reason
    Process Change - Manufacturer/Sterilizer/Packager/Supplier
    Expedited Review
    N

    Advisory Committee Statement

    modifications to the purification process utilized in the manufacturing of NaHA bulk intermediate batches to optimize the ability to remove contaminants and to improve yield. Proposed modifications include increasing the amount of activated charcoal, Celatom and water for injection for the 1 kg and 1.5 kg batch sizes as well as two additional ethanol washes for the 1.5 kg batch size

    Classifications

    This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

    Product Code Device Name
    MOZ Acid, Hyaluronic, Intraarticular